Ekachai Medical Care PCL (BKK:EKH) ROE %: 9.38% (As of Mar. 2026) — 35% Below Median


BKK:EKH Ekachai Medical Care PCL BKK:EKH
89 GF Score
Price ฿5.05
GF Value ฿6.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ekachai Medical Care PCL ROE %?

Ekachai Medical Care PCL BKK:EKH 89 ROE % is 9.38% as of Mar. 2026, which is 35% below its 10-year median of 14.44. GuruFocus rates BKK:EKH with a GF Score™ of 89/100 and a GF Value™ of ฿6.13 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Ekachai Medical Care PCL ranks better than 65.49% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Ekachai Medical Care PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿225 Mil. Ekachai Medical Care PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿2,400 Mil. Therefore, Ekachai Medical Care PCL's annualized ROE % for the quarter that ended in Mar. 2026 was 9.38%.

The historical rank and industry rank for Ekachai Medical Care PCL's ROE % or its related term are showing as below:

BKK:EKH' s ROE % Range Over the Past 10 Years
Min: 8.28   Med: 14.44   Max: 36.86
Current: 10.83

During the past 11 years, Ekachai Medical Care PCL's highest ROE % was 36.86%. The lowest was 8.28%. And the median was 14.44%.

BKK:EKH's ROE % is ranked better than
65.49% of 623 companies
in the Healthcare Providers & Services industry
Industry Median: 5.86 vs BKK:EKH: 10.83

Ekachai Medical Care PCL  (BKK:EKH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=225.084/2400.113
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(225.084 / 1224.736)*(1224.736 / 2971.122)*(2971.122 / 2400.113)
=Net Margin %*Asset Turnover*Equity Multiplier
=18.38 %*0.4122*1.2379
=ROA %*Equity Multiplier
=7.58 %*1.2379
=9.38 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=225.084/2400.113
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (225.084 / 322.004) * (322.004 / 269.568) * (269.568 / 1224.736) * (1224.736 / 2971.122) * (2971.122 / 2400.113)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.699 * 1.1945 * 22.01 % * 0.4122 * 1.2379
=9.38 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Ekachai Medical Care PCL ROE % Related Terms


Ekachai Medical Care PCL ROE % Historical Data

* Premium members only.

The historical data trend for Ekachai Medical Care PCL's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekachai Medical Care PCL ROE % Chart

Ekachai Medical Care PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.08 36.86 14.82 11.73 10.39

Ekachai Medical Care PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.25 7.81 12.84 14.02 9.38

BKK:EKH vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Ekachai Medical Care PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekachai Medical Care PCL ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ekachai Medical Care PCL's ROE % distribution charts can be found below:

* The bar in red indicates where Ekachai Medical Care PCL's ROE % falls into.


BKK:EKH
89GF Score
Ekachai Medical Care PCL BKK:EKH
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekachai Medical Care PCL ROE % Calculation

Ekachai Medical Care PCL's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=262.302/( (2674.982+2371.978)/ 2 )
=262.302/2523.48
=10.39 %

Ekachai Medical Care PCL's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=225.084/( (2371.978+2428.248)/ 2 )
=225.084/2400.113
=9.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 9.38% mean?
Ekachai Medical Care PCL (BKK:EKH) has a ROE % of 9.38% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ekachai Medical Care PCL and its competitors. This is 35% below median its historical median of 14.44. Over the past decade, Ekachai Medical Care PCL's ROE % has ranged from 8.28 to 36.86. According to the industry distribution chart, Ekachai Medical Care PCL ranks #215 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 34.5%.
Is Ekachai Medical Care PCL's ROE % too high?
Ekachai Medical Care PCL's current ROE % of 9.38% is 35% below median its 10-year median of 14.44. Over the past 10 years, this metric has ranged from a low of 8.28 to a high of 36.86. The Healthcare Providers & Services industry median ROE % is 5.86. Ekachai Medical Care PCL's value of 9.38% is 60.1% above this industry median. Based on the distribution chart, Ekachai Medical Care PCL ranks #215 out of 623 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ekachai Medical Care PCL has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ekachai Medical Care PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ekachai Medical Care PCL ranks #215 out of 623 companies for ROE %. This puts Ekachai Medical Care PCL in the upper half of its industry. The industry median ROE % is 5.86. Ekachai Medical Care PCL's value of 9.38% is 60.1% above this benchmark. Historically, Ekachai Medical Care PCL's own ROE % has ranged from 8.28 to 36.86 over the past decade. While the company's 10-year median is 14.44 vs. the industry median of 5.86, Ekachai Medical Care PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.86, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ekachai Medical Care PCL's current ROE % of 9.38% is 60.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ekachai Medical Care PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ekachai Medical Care PCL's current ROE % is 9.38%, which is 35% below median its own 10-year median of 14.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekachai Medical Care PCL stock overvalued right now?
Based on GuruFocus' analysis, Ekachai Medical Care PCL (BKK:EKH) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿6.13, compared to a current price of ฿5.05 — trading 17.6% below its estimated fair value. The current ROE % is 9.38%, which is 35% below median its 10-year median of 14.44 and 60.1% above the Healthcare Providers & Services industry median of 5.86. Ekachai Medical Care PCL's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Ekachai Medical Care PCL (BKK:EKH), the current ROE % is 9.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekachai Medical Care PCL (BKK:EKH) Overvalued in 2026?

Based on GuruFocus' analysis, Ekachai Medical Care PCL stock appears to be undervalued. The current stock price of ฿5.05 is trading 17.6% below its estimated GF Value™ of ฿6.13. GuruFocus considers Ekachai Medical Care PCL to be Modestly Undervalued.

Key valuation signals for BKK:EKH:

  • ROE %: 9.38% (35% below median its 10-year median of 14.44)
  • GF Value™: ฿6.13 vs. price of ฿5.05 (17.6% below fair value)
  • GF Score™: 89/100 with 3 warning signs
  • Industry Position: 60.1% above the Healthcare Providers & Services median (#215 of 623)

No single metric tells the full story. See the BKK:EKH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ekachai Medical Care PCL Business Description

Address 99/9 Moo 4, Ekachai Road, Khok-kham, Muang Samut Sakorn, Samut Sakorn, THA, 74000
Ekachai Medical Care PCL is engaged in hospital business. Its services include plastic surgery, IVF Fertility & Genetic Center, Ophthalmology Center, Obstertrics and Gynaecology Center, Pediatrics Center, Orthopedics Center, General Surgery Center, Dental center, therapy, Aesthetic & Dermatology Center, among others. The group is engaged in the hospital business and infertility center. Its operations are carried on only in Thailand.
89GF Score

Get the complete analysis for BKK:EKH

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.05
Price
฿6.13
GF Value